GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cartesian Therapeutics Inc (FRA:1S70) » Definitions » General and Admin. Expense

Cartesian Therapeutics (FRA:1S70) General and Admin. Expense : €27.90 Mil (TTM As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Cartesian Therapeutics General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Cartesian Therapeutics's General and Admin. Expense for the three months ended in Dec. 2024 was €6.77 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2024 was €27.90 Mil.

Cartesian Therapeutics General and Admin. Expense Historical Data

The historical data trend for Cartesian Therapeutics's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cartesian Therapeutics General and Admin. Expense Chart

Cartesian Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.55 18.53 22.53 37.09 28.77

Cartesian Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.21 8.69 6.53 5.91 6.77

Cartesian Therapeutics General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €27.90 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cartesian Therapeutics General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Cartesian Therapeutics's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Cartesian Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cartesian Therapeutics Inc (FRA:1S70) » Definitions » General and Admin. Expense
Comparable Companies
KALV CELC TRDA ARCT MLYS CADL AUTL MAZE RAPP CGEM VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
RNAC:USA
Address
7495 New Horizon Way, Frederick, MD, USA, 21703
Website
https://www.cartesiantherapeutics.com
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.

Cartesian Therapeutics Headlines

No Headlines